Ad is loading...
DODGX
Price
$280.71
Change
-$1.97 (-0.70%)
Updated
Nov 15 closing price
JCVVX
Price
$37.35
Change
-$0.15 (-0.40%)
Updated
Nov 15 closing price
Ad is loading...

DODGX vs JCVVX

Header iconDODGX vs JCVVX Comparison
Open Charts DODGX vs JCVVXBanner chart's image
Dodge & Cox Stock I
Price$280.71
Change-$1.97 (-0.70%)
VolumeN/A
CapitalizationN/A
JHancock Classic Value R5
Price$37.35
Change-$0.15 (-0.40%)
VolumeN/A
CapitalizationN/A
DODGX vs JCVVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DODGX vs. JCVVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a StrongBuy and JCVVX is a Buy.

FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 115B vs. JCVVX (1.26B). JCVVX pays higher dividends than DODGX: JCVVX (1.49) vs DODGX (1.36). DODGX was incepted earlier than JCVVX: DODGX (60 years) vs JCVVX (16 years). JCVVX is a more actively managed with annual turnover of: 24.00 vs. DODGX (12.00). JCVVX has a lower initial minimum investment than DODGX: JCVVX (0) vs DODGX (2500). DODGX annual gain was more profitable for investors over the last year : 24.42 vs. JCVVX (12.55). DODGX return over 5 years is better than : 48.65 vs. JCVVX (19.26).
DODGXJCVVXDODGX / JCVVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence60 years16 years-
Gain YTD16.6107.358226%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets115B1.26B9,120%
Annual Yield % from dividends1.361.4992%
Returns for 1 year24.4212.55195%
Returns for 3 years15.52-5.98-259%
Returns for 5 years48.6519.26253%
Returns for 10 years63.2156.85111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOST40.600.24
+0.59%
Toast
OUT17.90-0.04
-0.22%
OUTFRONT Media
FLWS7.80-0.09
-1.14%
1-800-FLOWERS.COM
SGMT4.73-0.45
-8.69%
Sagimet Biosciences
UPC0.14-0.02
-13.20%
Universe Pharmaceuticals